Stocksigma LogoStocksigma Logo

Evonile Pharma Board to Consider Rights Issue on 8th Oct'26

Evonile Pharma Limited (formerly Novartis India Limited) announced that its Board of Directors is scheduled to meet on 8th Oct'26 to consider raising funds

Evonile Pharma Board to Consider Rights Issue on 8th Oct'26

Novartis India Ltd · Intimation · 08 Oct 2026, 5:30 am

Evonile Pharma Board to Consider Rights Issue on 8th Oct'26 Evonile Pharma Limited (formerly Novartis India Limited) announced that its Board of Directors is scheduled to meet on 8th Oct'26 to consider raising funds via a rights issue of equity shares with a face value of ₹5 each to eligible equity shareholders. The proposed capital raise remains subject to board approval and requisite statutory clearances. Meanwhile, the company's trading window for designated persons remains closed from 1st Oct'26 until 5th Nov'26, covering both the rights issue discussion and the Q2 financial results declaration.

Original exchange filing (PDF)

More announcements from Novartis India Ltd

All Novartis India Ltd announcements